| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 9.759.182 $ | 95,97 | 570.439 | |||||||
| Enliven Therapeutics Inc | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 239.159 $ | 2,35 | 6.101 | |
| Corcept Therapeutics Inc. | Corcept Therapeutics, Inc. | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 223.761 $ | 2,20 | 5.551 | |
| Terns Pharmaceuticals Inc. | Terns Pharmaceuticals, Inc. | EC | 880881107 | Long | Börsenkurs (Stufe 1) | 211.091 $ | 2,08 | 4.004 | |
| Perrigo Company PLC | Perrigo Company plc | EC | G97822103 | Long | Börsenkurs (Stufe 1) | 205.048 $ | 2,02 | 19.092 | |
| Axsome Therapeutics Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 198.429 $ | 1,95 | 1.174 | |
| Innoviva Inc | Innoviva, Inc. | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 194.648 $ | 1,91 | 8.354 | |
| Merck & Co., Inc | Merck & Company, Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 193.907 $ | 1,91 | 1.612 | |
| Pfizer Inc. | Pfizer, Inc. | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 192.629 $ | 1,89 | 6.860 | |
| Royalty Pharma PLC | Royalty Pharma plc | EC | G7709Q104 | Long | Börsenkurs (Stufe 1) | 192.408 $ | 1,89 | 4.011 | |
| Elanco Animal Health Inc | Elanco Animal Health, Inc. | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 191.129 $ | 1,88 | 7.987 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals plc | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 190.941 $ | 1,88 | 1.010 | |
| Esperion Therapeutics Inc | Esperion Therapeutics, Inc. | EC | 29664W105 | Long | Börsenkurs (Stufe 1) | 190.786 $ | 1,88 | 69.630 | |
| Edgewise Therapeutics Inc. | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 190.355 $ | 1,87 | 6.043 | |
| MBX Biosciences, Inc. | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 190.115 $ | 1,87 | 6.369 | |
| Definium Therapeutics Inc. | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 190.002 $ | 1,87 | 10.053 | |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 189.410 $ | 1,86 | 3.123 | |
| ANI Pharmaceuticals Inc. | ANI Pharmaceuticals, Inc. | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 188.790 $ | 1,86 | 2.455 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 188.463 $ | 1,85 | 771 | |
| Tarsus Pharmaceuticals Inc | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 188.002 $ | 1,85 | 2.680 | |
| Trevi Therapeutics Inc | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 187.134 $ | 1,84 | 15.686 | |
| Pacira Biosciences Inc | Pacira BioSciences, Inc. | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 185.410 $ | 1,82 | 8.204 | |
| Zoetis Inc. | Zoetis, Inc. | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 184.762 $ | 1,82 | 1.563 | |
| Crinetics Pharmaceuticals Inc. | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 183.961 $ | 1,81 | 5.065 | |
| Nektar Therapeutics | Nektar Therapeutics | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 183.760 $ | 1,81 | 2.554 | |
| Liquidia Corporation | Liquidia Corporation | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 183.303 $ | 1,80 | 4.857 | |
| Amneal Pharmaceuticals Inc | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 183.156 $ | 1,80 | 14.735 | |
| Harmony Biosciences Holdings Inc | Harmony Biosciences Holdings, Inc. | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 182.205 $ | 1,79 | 6.505 | |
| Supernus Pharmaceuticals, Inc | Supernus Pharmaceuticals, Inc. | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 181.897 $ | 1,79 | 3.519 | |
| Viatris Inc | Viatris, Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 181.115 $ | 1,78 | 13.406 | |
| Xeris Biopharma Holdings Inc | Xeris Biopharma Holdings, Inc. | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 179.522 $ | 1,77 | 30.952 | |
| Harrow Inc | Harrow, Inc. | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 178.768 $ | 1,76 | 5.070 | |
| Organon & Co | Organon & Company | EC | 68622V106 | Long | Börsenkurs (Stufe 1) | 175.291 $ | 1,72 | 29.264 | |
| Nuvation Bio Inc | Nuvation Bio, Inc. | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 175.045 $ | 1,72 | 40.803 | |
| Phibro Animal Health Corporation | Phibro Animal Health Corporation | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 174.835 $ | 1,72 | 3.161 | |
| Amylyx Pharmaceuticals Inc | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 174.362 $ | 1,71 | 12.544 | |
| Indivior Pharmaceuticals Inc. | Indivior Pharmaceuticals, Inc. | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 173.888 $ | 1,71 | 5.705 | |
| Collegium Pharmaceutical Inc. | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 173.882 $ | 1,71 | 5.258 | |
| Eli Lilly & Co. | Eli Lilly & Company | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 171.997 $ | 1,69 | 187 | |
| Prestige Consumer Healthcare Inc | Prestige Consumer Healthcare, Inc. | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 171.290 $ | 1,68 | 2.890 | |
| Ligand Pharmaceuticals Incorporated | Ligand Pharmaceuticals, Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 169.104 $ | 1,66 | 847 | |
| Ocular Therapeutix Inc | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 166.986 $ | 1,64 | 19.715 | |
| Omeros Corp | Omeros Corporation | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 165.781 $ | 1,63 | 15.699 | |
| Eyepoint Inc. | EyePoint Pharmaceuticals, Inc. | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 161.808 $ | 1,59 | 12.553 | |
| Alumis Inc | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 156.633 $ | 1,54 | 7.110 | |
| Amphastar Pharmaceuticals Inc | Amphastar Pharmaceuticals, Inc. | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 141.499 $ | 1,39 | 7.223 | |
| Phathom Pharmaceuticals Inc | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 140.597 $ | 1,38 | 12.655 | |
| Theravance Biopharma Inc | Theravance Biopharma, Inc. | EC | G8807B106 | Long | Börsenkurs (Stufe 1) | 138.409 $ | 1,36 | 8.528 | |
| Rapport Therapeutics Inc | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 133.514 $ | 1,31 | 4.267 | |
| Arvinas Inc | Arvinas, Inc. | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 121.762 $ | 1,20 | 11.487 | |
| CorMedix Inc. | CorMedix, Inc. | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 119.402 $ | 1,17 | 17.585 | |
| BioAge Labs Inc. | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 117.061 $ | 1,15 | 6.693 | |
| Maze Therapeutics Inc | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 110.833 $ | 1,09 | 3.713 | |
| Septerna Inc. | Septerna, Inc. | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 98.066 $ | 0,96 | 4.081 | |
| Wave Life Sciences Ltd. | WaVe Life Sciences Ltd. | EC | Y95308105 | Long | Börsenkurs (Stufe 1) | 96.440 $ | 0,95 | 13.302 | |
| Zevra Therapeutics Inc | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 96.061 $ | 0,94 | 10.307 | |
| Fulcrum Therapeutics Inc | Fulcrum Therapeutics, Inc. | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 89.478 $ | 0,88 | 11.666 | |
| Aquestive Therapeutics Inc | Aquestive Therapeutics, Inc. | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 79.037 $ | 0,78 | 19.045 | |
| LB Pharmaceuticals Inc. | LB Pharmaceuticals, Inc. | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 69.788 $ | 0,69 | 2.830 | |
| Alto Neuroscience Inc | Alto Neuroscience Inc | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 52.266 $ | 0,51 | 2.325 | |
| 9.759.182 $ | 95,97 | 570.439 |